Biochemical and histopathological evidences for beneficial effects of Satureja Khuzestanica Jamzad essential oil on the mouse model of inflammatory bowel diseases

Toxicology Mechanisms and Methods

Volumn 16, Issue 7, 2006, Pages 365-372

  Ghazanfari, Ghazal ^a   Minaie, Bagher ^b   Yasa, Narges ^c   Nakhai, Leila ^a   Mohammadirad, Azadeh ^a   Nikfar, Shekoufeh ^a   Dehghan, Gholamreza ^a   Boushehri, Vahid ^a   Jamshidi, Hamidreza ^a   Khorasani, Reza ^a   Salehnia, Alinazar ^a   Abdollahi, Mohammad ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Essential oil myeloperoxidase; Inflammatory bowel disease; Lipid peroxidation; Satureja khuzestanica

Indexed keywords

ACETIC ACID; ESSENTIAL OIL; MYELOPEROXIDASE; PLANT EXTRACT; PREDNISOLONE; SATUREJA KHUZESTANICA JAMZAD EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BIOCHEMISTRY; COLITIS; COLON; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; ENTERITIS; ENZYME ACTIVITY; HISTOPATHOLOGY; LIPID PEROXIDATION; MEDICINAL PLANT; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SATUREJA KHUZESTANICA JAMZAD;

ANIMALIA; SATUREJA;

EID: 33746176093     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.1080/15376520600620125     Document Type: Article

References (46)

1. Abad, M. J., Bermejo, P., Gonzales, E., Iglesias, I., Irurzun, A., and Carrasco, L. 1999. Antiviral activity of Bolivian plant extracts. Gen. Pharmacol. 32:499-503.
2. Abdollahi, M., Bahreini-Moghadam, A., Emami, B., Fooladian, F., and Zafari, K. 2003c. Increasing intracellular cAMP and cGMP inhibits cadmium-induced oxidative stress in rat submandibular saliva. Comp. Biochem. Physio. C. Toxicol. Pharmacol. 135:331-336.
3. Abdollahi, M., Chan, T. S., Subrahmanyam, V., and O'Brien, P. J. 2003b. Effects of phosphodiesterase 3,4,5 inhibitors on hepatocyte cAMP levels, glycogenolysis, gluconeogenesis and susceptibility to a mitochondrial toxin. Mol. Cell. Biochem. 252:205-211.
4. Abdollahi, M., Fooladian, F., Emami, B., Zafari, K., and Bahreini-Moghadam, A. 2003d. Protection by sildenafil and theophylline of lead acetate-induced oxidative stress in rat submandibular gland and saliva. Hum. Exp. Toxicol. 22:587-592.
5. Abdollahi, M., Ranjbar, A., Shadnia, S., Nikfar, S., and Rezaiee, A. 2004. Pesticides and oxidative stress: a review. Med. Sci. Monit. 10(6):RA144-RA147.
6. Abdollahi, M., Salehnia, A., Mortazavi, S. H. R., Ebrahimi, M., Shafiee, A., Fouladian, F., Keshavarz, K., Sorouri, S., Khorasani, R., and Kazemi, A. 2003a. Antioxidant, antidiabetic, antihyperlipidemic, reproduction stimulatory properties and safety of Satureja Khuzestanica essential oil as in rat in vivo; a toxicopharmacological study. Med. Sci. Monit. 9(9):BR331-335.
7. Aghababaeian, R., Ghazi-Khansari, M., Abdi, K., Taghadosinejad, F., and Abdollahi, M. 2005. Protective effects of sildenafil and dipyridamol from lead-induced lipid peroxidation in perfused rat liver. I. J. P. 1(2):157-160.
8. Amanlou, M., Dadkhah, F., Salehnia, A., Farsam, H., and Dehpour, A. R. 2005. An anti-inflammatory and anti-nociceptive effects of hydroalcoholic extract of Satureja khuzistanica Jamzad extract. J. Pharm. Pharm. Sci. 8(1):102-106.
9. Amanlou, M., Fazeli, M. R., Arvin, A., Amin, H. G., and Farsam, H. 2004. Antimicrobial activity of crude methanolic extract of Satureja khuzistanica. Fitoterapia 75(7-8):768-770.
10. Arnhold, J. 2004. Properties, functions, and secretion of human myeloperoxidase. Biochemistry (Mosc) 69(1):4-9.
11. Azaz, D., Demirci, F., Satil, F., Kurkcuoglu, M., and Baser, K. H. 2002. Antimicrobial activity of some Satureja essential oils. Z. Naturforsch 57:817-821.
12. Botoman, V. A., Bonner, G. F., and Botoman, D. A. 1998. Management of inflammatory bowel disease. Am. Fam. Physician 57(1):71-72.
13. Cortés, A. A. R., Zurita, C. N. D., Domínquez-R, A., Hurtado, M., and Aoki, M. K. 2004. Preliminary pharmacologic and toxicological studies on Satureja macrostema Benth. Rev. Mex. Ciencias Farma. 35(3):15-19.
14. El-Gazzar, A., and Watson, L. 1970. A taxonomic study of Labiatae and related genera. New Phytol. 69:451-486.
15. Elson, C. O., Cong, Y., Brandwein, S., Weaver, C. T., McCabe, R. P., Mahler, M., Sundberg, J. P., and Leiter, E. H. 1998. Experimental models to study molecular mechanisms underlying intestinal inflammation. Ann. N.Y. Acad. Sci. 859:85-95.
16. Elson, C. O., Sartor, R. B., Tennyson, G. S., and Riddell, R. H. 1995. Experimental models of inflammatory bowel disease. Gastroenterology 109(4):1344-1367.
17. Farsam, H., Amanlou, M., Radpour, M. R., Salehinia, A. N., and Shafiee, A. 2004. Composition of the essential oils of wild and cultivated Satureja khuzistanica Jamzad from Iran. Flav. Frag. J. 19(4):308-310.
18. Gibson, P. R., and Iser, J. 2005. Inflammatory bowel disease. Aust. Fam. Physician 34(4):233-237.
19. Grisham, M. B. 1994. Oxidants and free radicals in inflammatory bowel disease. Lancet 344:859-861.
20. Grisham, M. B., and Granger, D. N. 1988. Neutrophil-mediated mucosal injury. Role of reactive oxygen metabolites. Dig. Dis. Sci. 33:6S-15S.
21. Hadjibabaie, M., Rastkari, N., Rezaie, A., and Abdollahi, M. 2005. The adverse drug reaction in the gastrointestinal tract: an overview. I. J. Pharmacol. 1(1):1-8.
22. Hajhashemi, V., Ghannadi, A., and Pezeshkian, S. K. 2002. Antinociceptive and anti-inflammatory effects of Satureja hortensis L. extracts and essential oil. J. Ethnopharmacol. 82:83-87.
23. Hajhashemi, V., Sadraei, H., Ghannadi, A. R., and Mohseni, M. 2000. Antispasmodic and anti-diarrhoeal effect of Satureja hortensis L. essential oil. J. Ethnopharmacol. 71:187-192.
24. Jagtap, A. G., Shirke, S. S., and Phadke, A. S. 2004. Effect of polyherbal formulation on experimental models of inflammatory bowel diseases. J. Ethnopharmacol. 90(2-3):195-204.
25. Jahanshahi, G., Motavasel, V., Rezaie, A., Hashtroudi, A. A., Daryani, N. E., and Abdollahi, M. 2004. Alterations in antioxidant power and levels of epidermal growth factor and nitric oxide in saliva of patients with inflammatory bowel diseases. Dig. Dis. Sci. 49:1752-1757.
26. Jamzad, Z. 1994. A new species of the genus Satureja (Labiatae) from Iran. Irn. J. Bot. 6:215-218.
27. Jurjus, A. R., Khoury, N. N., and Reimund, J. M. 2004. Animal models of inflammatory bowel disease. J. Pharmacol. Toxicol. Methods 50(2):81-92.
28. Katzung, B. G. 2000. Basic & Clinical Pharmacology, 8th ed., New York: Appleton & Lange.
29. Krawisz, J. E., Sharon, P., and Stenson, W. F. 1984. Qualitative assay for acute intestinal inflammation based on myeloperoxidase activity. Gastroenterology 87:1344-1350.
30. Lambert, R. J., Skandamis, P. N., Coote, P. J., and Nychas, G. J. 2001. A study of the minimum inhibitory concentration and mode of action of oregano essential oil, thymol and carvacrol. J. Appl. Microbiol. 91:453-462.
31. MacPherson, B., and Pfeiffer, C. J. 1976. Experimental colitis. Digestion 14:424-452.
32. Milani, E., Nikfar, S., Khorasani, R., Zamani, M. J., and Abdollahi, M. 2005. Reduction of diabetes-induced oxidative stress by phosphodiesterase inhibitors in rats. Comp. Biochem. Physiol. C. Toxicol. Pharmacol. 140(2):251-255.
33. Ogawa, Y., Kanatsu, K., Iino, T., Kato, S., Jeong, Y. I., Shibata, N., Takada, K., and Takeuchi, K. 2002. Protection against dextran sulfate sodium-induced colitis by microspheres of ellagic acid in rats. Life Sci. 71(7):827-839.
34. Radfar, M., Larijani, B., Hadjibabaie, M., Rajabipour, B., Mojtahedi, A., and Abdollahi, M. 2005. Effects of pentoxifylline on oxidative stress and levels of EGF and NO in blood of diabetic type-2 patients; a randomized, double-blind placebo-controlled clinical trial. Biomed. Pharmacoth. 59:302-306.
35. Rezaie, A., Taghavi, B., and Abdollahi, M. 2005. Biologic management of fistulizing Crohn's disease. I. J. P. 1(1):17-24.
36. Rumi, G., Tsubouchi, R., Okayama, M., Kato, S., Mozsik, G., and Takeuchi, K. 2004. Protective effect of lactulose on dextran sulfate sodium-induced colonic inflammation in rats. Dig. Dis. Sci. 49(9):1466-1472.
37. Saadat, M., Pournourmohammadi, S., Donyavi, M., Khorasani, R., Amin, G., Salehnia, A. N., and Abdollahi, M. 2004. Alteration of rat hepatic glycogen phosphorylase and phosphoenolpyruvate carboxykinase activities by Satureja khuzestanica Jamzad essential oil. J. Pharm. Pharm. Sci. 7(3):327-331.
38. Sanchez de Rojas, V., Somoza, B., Ortega, T., Villar, A. M., and Tejerina, T. 1999. Vasodilatory effect in rat aorta of eriodictyol obtained from Satureja obovata. Planta. Med. 65:234-238.
39. Satho, K. 1978. Serum lipid peroxidation in cerebrovascular disorders determined by a new colorimetric method. Clin. Chem. Acta. 90:37-43.
40. Sefidkon, F., and Ahmadi, S. 2000. Essential oil of Satureja Khhuzistanica Jamzad. J. Ess. Oil Res. 12:427-428.
41. Sharon, P., and Stenson, W. F. 1985. Metabolism of arachidonic acid in acetic acid colitis in rats. Gastroenteroloogy 88:55-63.
42. Slavkovska, V., Jancic, R., Bojovic, S., Milosavljevic, S., and Djokovic, D. 2001. Variability of essential oils of Satureja montana L. and Satureja kitaibelii wierzb. ex Heuff. from the central part of the balkan peninsula. Phytochemistry 57:71-76.
43. Sokovic, M., Tzakou, O., Pitarokili, D., and Couladis, M. 2002. Antifungal activities of selected aromatic plants growing wild in Greece. Nahrung 46:317-320.
44. Yamasaki, K., Nakano, M., Kawahata, T., Mori, H., Otake, T., Ueba, N., Oishi, I., Inami, R., Yamane, M., Nakamura, M., Murata, H., and Nakanishi, T. 1998. Anti-HIV-1 activity of herbs in Labiatae. Biol. Pharm. Bull. 21:829-833.
45. Zamani, M. J., Sharifzadeh, M., Rezaie, A., Mashayekhi, F., and Abdollahi, M. 2005. Effects of sildenafil on rat irritable bowel syndrome. Therapy 2(2):237-242.
46. Zargari, A. 1990. Medicinal Plants, 4th ed., Tehran University Publications, Tehran.